DL-Tryptophan Market to Rear Excessive Growth | 2024
Tryptophan,
a dietary supplement, is an amino acid segregated into the
L-tryptophan, D-tryptophan, and DL-tryptophan varieties. While the
L-tryptophan can only be absorbed by humans and animals,
DL-tryptophan is an amino acid predecessor of melatonin and
serotonin. It occurs as a white to yellowish-white crystalline powder
or crystals and exhibits a mildly sweet taste and a faint to
non-existent odor. The global surge in the production of livestock
due to increasing consumption of meat is expected to drive the market
for amino acids and therefore, DL-tryptophan, over the forecast
period.
Read
Report Overview @
DL-tryptophan
finds application in the chemical, food & dietary supplements,
animal feed, and pharmaceuticals industry, of which the feed sector
was globally dominant in 2015. Tryptophan, methionine, threonine, and
lysine are widely used in animal feed additives, which offer health
benefits with respect to weight gain and high metabolism. Growing
consumption of meat in Asia Pacific and Latin America and the
introduction of innovative animal-based and plant-based acids are
predicted to provide tremendous opportunities to market players. Food
& dietary supplements are also major applications of
DL-tryptophan, estimated to witness significant growth due to the
constantly changing food habits of consumers. The product’s
pharmaceutical applications are also increasing at a significant rate
owing to its usage as a buffering agent in analgesics,
antiperspirants, and antacids. Thus, demand for it in the
pharmaceuticals industry is rising along with the consumers’
standards of living and purchasing power. However, escalating prices
of raw materials such as soybean, wheat, and corn are projected to
impact the market profitability and act as a restraint during the
forecast period. Expansion of marginal sources of proteins for
animals is a major challenge faced by the DL-tryptophan market.
Manufacturers are currently focusing on innovative techniques in
order to increase their production capacity and cut costs.
Asia
Pacific is a key consumer of DL-tryptophan. China is a major producer
and exporter of livestock for the domestic industry due to the
presence of numerous small-scale players in this country. Growing
livestock production mainly in China, India, and parts of South East
Asia is likely to propel the market in this region. Latin America is
estimated to witness significant growth during the forecast period.
The growing demand for and consumption of meat as well as health
awareness in Brazil are projected to motivate the market in Latin
America. DL-tryptophan is supplied all across the U.S., Canada, and
the U.K. as an anxiolytic and antidepressant. It is also promoted as
a prescription drug in a few countries in Europe under several trade
names.
Growing
demand for dietary supplements has led to improved health standards.
The rising geriatric population particularly in the emerging markets
of Asia Pacific and Latin America is also estimated to propel the
market. Europe is anticipated to display a moderate pace of growth
due to the increasing demand for dietary and food supplements in the
region. The market in North America is likely to expand at a steady
rate over the forecast period owing to rising incidences of
cardiovascular diseases and obesity boosting the need for food &
dietary supplements in the region.
Request
to view Sample Report:
Key
players in the global DL-tryptophan market include Cargill Inc.,
Sunrise Nutrachem Group, Evonik Industries AG, Ajinomoto Co., Royal
DSM, Iris Biotech GmbH, Prinova U.S. LLC, Tokyo Chemical Industry,
Nanjing Liang Chemical, Novus International Inc., Adisseo France SAS,
CJ Cheil Jedang Corporation, and Anaspec Inc.
Comments
Post a Comment